A novel MMP-9 inhibitor exhibits selective inhibition in non-small-cell lung cancer harboring EGFR T790M mutation by blocking EGFR/STAT3 signaling pathway

Liangping Li(First Affiliated Hospital of Jinan University), Guohai Zhang(Guangxi Normal University), Shulan Zeng(Guangxi Normal University), Hui Wang(East China Normal University), Xuesong Ma(Guangxi Normal University), Wenqing Du(Guangxi Normal University), Min Lu(South China Agricultural University), Yan Peng(Guangxi Normal University)
Bioorganic Chemistry
March 21, 2025
10.1016/j.bioorg.2025.108393
Cited by 5

Related Papers

Proteome Analysis of Hepatocellular Carcinoma by Two-dimensional Difference Gel Electrophoresis
|Molecular & Cellular Proteomics|2007|247
Macroscopic somatic clonal expansion in morphologically normal human urothelium
|Science|2020|221
Effect of Remote Ischemic Conditioning vs Usual Care on Neurologic Function in Patients With Acute Moderate Ischemic Stroke
|JAMA|2022|185
Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2021|182
Inhibition of Ca2+-activated Cl− channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma
|Cancer Letters|2012|168